The purpose of this business plan is to raise enough money to manufacture artificial joint replacements and hire scientists and researchers to continue to improve our products with new advances in technology. JointRx is dedicated to providing our quality product to all hospitals around the nation.
The Team
The management team will be composed of four highly qualified individuals who are trained specifically for their job roles. They all have helped run similar corporations to JointRx and have been successful in keeping those businesses alive. They were all specifically chosen because they are believed to be critical in the foundation and maintenance of this company. The investor will be alloted two seats on the board and out of the four individuals on the management team one will be appointed as chairman.
Product
JointRx will be producing osteopathic artificial joint replacements for the knee, hip, ankle and shoulder joints. These joint replacements will increase joint mobility and decrease pain with movement.
Strategy
Our initial strategy is quite simple. Because our management team is made up of four members that have perviously run similar companies they have plenty of contacts in many hospitals around the nation. We therefore can advertise our company very easily by supplying our product to those contacts and branching out from there.
Our Edge
The world of osteopathic sales has become a great industry to invest in, especially in the past decade or so. Because of new technology our company will able to grow tremendously by creating and supplying more reliable products. The world today relies on being able to get around efficiently and therefore many people will pay a lot of money in order to move around with joints that allow them to live their lives easier and virtually pain free. Our company would also allow for money to be made in many areas in artificial joints because the human body provides us with many joints to injure therefore enabling technicians and scientists to create the best possible solution for each particular joint. We are no where close to knowing every aspect of the human body and therefore we can not predict every effect artificial joints will have on the body. This allows for more research and knowledge in this area which will only help expand our company and make it both more popular and profitable.
Financial Statement
We are seeking $30 million US dollars from an investor that has some experience in the medical or marketing industries. The investor in return will receive the following benefits:
-two seats on the board of directors
-40% equity in JointRx
-10 times the original investment by year 7